The present findings reinforce the potential of BA, a natural compound as an anti-inflammatory drug candidate consider the role of TLR-9/NF-κB /IL-18 as another important mediator involved in the immune regulation produced by the APAP and indicate the carrying out of future clinical evaluations involving BA effect on severe liver diseases. Here, NFKB1 is linked to liver disorder.